Clinical Research Directory
Browse clinical research sites, groups, and studies.
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor
Sponsor: Peking Union Medical College Hospital
Summary
68Ga-DOTA-dPNE PET/CT imaging was performed on patients with malignant tumors to observe the binding of lesions with the tracer and evaluate the expression of CD73. At the same time, correlation analysis was performed combined with relevant clinical indicators to evaluate the efficacy of 68Ga-DOTA-dPNE in the diagnosis and guidance of malignant tumor patients, and predict the response of targeted therapy.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-03-01
Completion Date
2026-03-30
Last Updated
2025-08-05
Healthy Volunteers
Yes
Conditions
Interventions
68GA-DOTA-dPNE
Intravenous administration of 68GA-DOTA-dPNE tracer
Locations (1)
PUMCH
Dongcheng, Beijing Municipality, China